Plocabulin ( PM184 ) Empieza a Posicionarse en la I+D+i Internacional . PharmaMar Tiene 5 Fármacos en Ensayos Clínicos : Yondelis, Aplidin, ZepZelCa, Plocabulin y PM-14 . Tres de Ellos Ya en el Mercado .

Interdimeric Curvature in Tubulin–Tubulin Complexes Delineates the Microtubule-Destabilizing Properties of Plocabulin .

Karen R. Navarrete and Verónica. A. Jiménez .

Publication Date : July 20, 2020 .

Copyright © 2020 American Chemical Society .

Abstract

Plocabulin is a Novel Microtubule (MT) destabilizer agent with potent antineoplastic activity. This compound binds to the maytansine site at the longitudinal interface between tubulin dimers and exerts a hinge-like effect that disrupts normal microtubule assembly. 

Plocabulin has emerged as a valuable model for the rational design of novel MT destabilizers because of its unique structural and mechanistic features. 

To make progress on this matter, detailed molecular-level understanding of the ligand–protein interactions responsible for Plocabulin association and the conformation and energetic effects arising from Plocabulin binding on the longitudinal interaction between tubulin dimers must be provided.

 In this work, fully atomistic MD simulations and MM/GBSA binding free-energy calculations were used to examine the association of plocabulin to one or two tubulin dimers in longitudinal arrangement.

 Our results revealed that Plocabulin binding is favored by the addition of a second tubulin dimer and that this ligand promotes the assembly of curved tetrameric arrangements with strengthened longitudinal interdimeric interactions compared to ligand-free systems. 

The Applicability of these findings to the rational discovery of novel MT destabilizers was tested using MD and MM/GBSA calculations as filtering tools to narrow the results of virtual screening among an FDA-approved drug database. 

Our Results Confirmed that tight-binding ligands do not necessarily exert the expected conformational and energetic effects on longitudinal tubulin–tubulin interactions, which is a matter to consider in future design strategies.

*********************************

P.J. : Plocabulin ( PM184 ) es un Inhibidor de Microtúbulos que Ejerce su Efecto Mediante un Nuevo Mecanismo de Interacción con Microtúbulos. El Compuesto Inhibe el Crecimiento de las Células tumorales Bloqueando su Ciclo Celular al Interferir con el Proceso de Mitosis.